Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer.
about
Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer.Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer.Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens.Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence.Improved survival in ovarian cancer, with widening survival gaps of races and socioeconomic status: a period analysis, 1983-2012
P2860
Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use and duration of chemothera ...... in early-stage ovarian cancer.
@ast
Use and duration of chemothera ...... in early-stage ovarian cancer.
@en
type
label
Use and duration of chemothera ...... in early-stage ovarian cancer.
@ast
Use and duration of chemothera ...... in early-stage ovarian cancer.
@en
prefLabel
Use and duration of chemothera ...... in early-stage ovarian cancer.
@ast
Use and duration of chemothera ...... in early-stage ovarian cancer.
@en
P2093
P2860
P1433
P1476
Use and duration of chemothera ...... in early-stage ovarian cancer.
@en
P2093
Alfred I Neugut
Ana I Tergas
Helen E Dinkelspiel
Jason D Wright
June Y Hou
Lilli A Zimmerman
William M Burke
P2860
P304
P356
10.1016/J.YGYNO.2015.02.013
P407
P577
2015-02-20T00:00:00Z